James M Markert (James Markert)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 9

Top Topics

Herpes Simplex Virus

Mesenchymal Stem Cells

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

Journal of immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Stacie K Totsch, Andrew S Ishizuka, Kyung-Don Kang, Sam E Gary, Abbey Rocco, Aaron E Fan, Li Zhou, Pablo A Valdés, Seung Ho Lee, Jason Li, Luca Peruzzotti-Jametti, Sarah E Blitz, Christopher M Garliss, James M Johnston, James M Markert, Geoffrey M Lynn, Joshua D Bernstock, Gregory K Friedman
Combination immunotherapy with vaccine and oncolytic HSV virotherapy is time dependent. Molecular cancer therapeutics (2024)
Stacie K Totsch, Andrew S Ishizuka, Kyung-Don Kang, Sam E Gary, Abbey Rocco, Aaron E Fan, Li Zhou, Pablo A Valdés, Seung Ho Lee, Jason Li, Luca Peruzzotti-Jametti, Sarah E Blitz, Christopher M Garliss, James M Johnston, James M Markert, Geoffrey M Lynn, Joshua D Bernstock, Gregory K Friedman
Combination immunotherapy with vaccine and oncolytic HSV virotherapy is time dependent. Molecular cancer therapeutics (2024)
Meagan Mandabach Olivet, Michael C Brown, Zachary J Reitman, David M Ashley, Gerald A Grant, Yuanfan Yang, James M Markert
Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults. Cancers 15 (15) (2023)
Katherine E Miller, Kevin A Cassady, Justin C Roth, Jennifer Clements, Kathleen M Schieffer, Kristen Leraas, Anthony R Miller, Nripesh Prasad, Jianmei Wu Leavenworth, Inmaculada B Aban, Richard J Whitley, G Yancey Gillespie, Elaine R Mardis, James M Markert
Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (3) (2022)
Colin H Quinn, Andee M Beierle, Sara Claire Hutchins, Raoud Marayati, Laura V Bownes, Jerry E Stewart, Hooper R Markert, Michael H Erwin, Jamie M Aye, Karina J Yoon, Gregory K Friedman, Christopher D Willey, James M Markert, Elizabeth Ann Beierle
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy. Cancers 14 (3) (2022)
Kyung-Don Kang, Joshua D Bernstock, Stacie K Totsch, Sam E Gary, Abbey Rocco, Li Nan, Rong Li, Tina Etminan, Xiaosi Han, Elizabeth Ann Beierle, Tanja Eisemann, Robert J Wechsler-Reya, Sejong Bae, Richard J Whitley, G Yancey Gillespie, James M Markert, Gregory K Friedman
Safety and efficacy of intraventricular immunovirotherapy with oncolytic HSV-1 for CNS cancers. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Douglas Kondziolka, James M Markert, Michael W McDermott, Shenandoah Robinson, E Sander Connolly
Commentary: Developing a Professionalism and Harassment Policy for Organized Neurosurgery. Neurosurgery 89 (1) (2021)
Corinne E Griguer, Claudia R Oliva, Christopher S Coffey, Merit E Cudkowicz, Robin A Conwit, Anna L Gudjonsdottir, Dixie J Ecklund, Janel K Fedler, Tina M Neill-Hudson, Louis B Nabors, Melanie Benge, James R Hackney, Marianne Chase, Timothy P Leonard, Toral Patel, Howard Colman, Macarena de la Fuente, Rekha Chaudhary, Karen Marder, Teri Kreisl, Nimish Mohile, Milan G Chheda, Katharine McNeill, Priya U Kumthekar, Aclan Dogan, Jan Drappatz, Vinay Puduvalli, Agnes Kowalska, Jerome Graber, Elizabeth Gerstner, Stephen Clark, Michael Salacz, James M Markert
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial. Neuro-oncology advances 4 (1) (2021)
David F Bauer, Larisa Pereboeva, G Yancey Gillespie, Gretchen A Cloud, Osama Elzafarany, Catherine Langford, James M Markert, Lawrence S Lamb
Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma. Journal of immunology research 2016 (2016)